Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to -$5.0 million.

  • IceCure Medical's Cash from Investing Activities fell 72149.07% to -$5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.0 million, marking a year-over-year decrease of 15495.2%. This contributed to the annual value of $446000.0 for FY2024, which is 16520.47% up from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's Cash from Investing Activities is -$5.0 million, which was down 72149.07% from -$23000.0 recorded in Q2 2025.
  • IceCure Medical's 5-year Cash from Investing Activities high stood at $8.7 million for Q4 2023, and its period low was -$15.1 million during Q1 2023.
  • In the last 5 years, IceCure Medical's Cash from Investing Activities had a median value of -$7000.0 in 2024 and averaged -$124631.6.
  • In the last 5 years, IceCure Medical's Cash from Investing Activities soared by 213981.48% in 2022 and then crashed by 1040000.0% in 2023.
  • Over the past 5 years, IceCure Medical's Cash from Investing Activities (Quarter) stood at -$179000.0 in 2021, then surged by 1036.31% to $1.7 million in 2022, then skyrocketed by 419.99% to $8.7 million in 2023, then plummeted by 100.08% to -$7000.0 in 2024, then tumbled by 71371.43% to -$5.0 million in 2025.
  • Its Cash from Investing Activities stands at -$5.0 million for Q3 2025, versus -$23000.0 for Q2 2025 and -$5000.0 for Q1 2025.